ZA202206078B
(en )
2023-11-29
Anti-cd3 antibodies and methods of use
MY191169A
(en )
2022-06-03
Anti-fcrh5 antibodies
PH12020550781A1
(en )
2021-08-02
Anti-jagged1 antibodies and methods of use
PH12018500711A1
(en )
2018-10-15
Anti-pd1 antibodies and methods of use
MX2020008436A
(en )
2020-09-25
ANTI-alpha-SYNUCLEIN ANTIBODIES AND METHODS OF USE.
PH12015501954A1
(en )
2016-01-18
Anti-b7-h4 antibodies and immunoconjugates
PH12017500877A1
(en )
2017-11-06
ANTI-CD79b ANTIBODIES AND METHODS OF USE
MX2015012326A
(en )
2016-03-08
Anti-crth2 antibodies and their use.
MX2017005920A
(en )
2017-06-27
Anti-tim3 antibodies and methods of use.
MX2015013901A
(en )
2015-12-11
Anti-il-4 antibodies and bispecific antibodies and uses thereof.
SG10201804931QA
(en )
2018-07-30
Anti-cll-1 antibodies and immunoconjugates
SG10201809668TA
(en )
2018-11-29
Anti-her2 antibodies and immunoconjugates
MX342240B
(en )
2016-09-21
Anti-fgfr4 antibodies and methods of use.
MX2014004022A
(en )
2014-04-30
ANTI-HtrA1 ANTIBODIES AND METHODS OF USE.
PH12014501605A1
(en )
2014-10-08
Anti-lrp5 antibodies and methods of use
MX2014014376A
(en )
2015-02-05
Anti-biotin antibodies and methods of use.
MX2016004853A
(en )
2016-07-19
ANTI-Ly6E ANTIBODIES AND METHODS OF USE.
MX357675B
(en )
2018-07-18
Anti-jagged anitbodies and methods of use.
MX353951B
(en )
2018-02-07
Anti-theophylline antibodies and methods of use.
MY192384A
(en )
2022-08-18
Anti-cd3 antibodies and methods of use
MX2015010789A
(en )
2015-11-26
Anti-mcsp antibodies.
AR117596A2
(en )
2021-08-18
ANTI-CD3 ANTIBODIES AND METHODS OF USE
CL2018002006A1
(en )
2018-08-31
Anti-cd3 antibodies and methods of use (divisional application 201601556)
EA201892257A1
(en )
2019-03-29
ANTI-CD3 ANTIBODIES AND METHODS OF APPLICATION